```
Sign in Subscribe
By Ainvest in options-flow —

PLTR: $205M Massive Call Flow (Nov 4)

After PLTR's 7. Institutional whale deploys $205M on PLTR options. Stock up 153.7% this year. Full breakdown reveals entry points, price targets, and trading strategies.

🚀 PLTR $141M in Massive Option Rolls - Sophisticated Repositioning After Post-Earnings Pullback! 💰

📅 November 4, 2025 | 🔥 Unusual Activity Detected

🎯 The Quick Take

After PLTR's 7.9% post-earnings selloff from $207 to $190, institutional players just executed $141 MILLION in complex option repositioning - rolling $116M out of near-term $160 calls into February while adding long-dated $200 call exposure. This isn't panic selling - it's sophisticated money adjusting timeframes after valuation concerns triggered profit-taking despite stellar Q3 results showing 63% revenue growth and explosive 121% U.S. commercial expansion.

📊 Company Overview

Palantir Technologies Inc. (PLTR) develops analytical software designed to help organizations optimize operations through data insights:
- Market Cap: $491.5 Billion (crossed $434B after Q3 earnings)
- Industry: Prepackaged Software (SIC: 7372)
- Current Price: $190.74 (down 7.9% post-earnings from $207 peak)
- Primary Business: AI platforms (AIP, Foundry for commercial, Gotham for government)
- YTD Performance: Up 154% despite recent pullback

💰 The Option Flow Breakdown

The Tape (November 4, 2025):

Time Symbol Buy/Sell Call/Put Expiration Premium Strike Volume OI Size Spot Option Price
09:52:33 PLTR BUY CALL 2026-02-20 $64M $160 15,000 1,900 15,000 $188.94 $42.45
09:56:10 PLTR BUY CALL 2026-02-20 $66M $160 30,000 1,900 15,000 $191.52 $44.30
12:24:53 PLTR SELL CALL 2025-11-21 $50M $160 15,000 32,000 14,900 $192.09 $33.67
12:24:53 PLTR BUY CALL 2026-01-16 $25M $200 19,000 20,000 14,900 $192.09 $16.85

🤓 What This Actually Means

This is a sophisticated roll and reposition strategy executed in multiple phases! Here's the breakdown:

Phase 1: Building February $160 Position ($130M)
- 💸 Two massive buys: $66M + $64M = $130M total premium paid
- 📊 Deep ITM positioning: $160 strike with PLTR trading at $191 = $31 intrinsic value
- 🎯 Total exposure: 30,000 contracts = 3 MILLION shares worth $573M
- ⏰ Long timeframe: February 2026 expiration (108 days out)

Phase 2: Rolling Out of November ($50M exit)
- 📤 Closing near-term: Sold 14,900 November 21st $160 calls for $50M
- ⚡ Timing: Just 17 days until expiration - taking profits before time decay accelerates
- 💰 Smart exit: Collected $33.67 per contract, likely up significantly from entry

Phase 3: Adding January $200 Calls ($25M)
- 🚀 Bullish lottery ticket: Bought 14,900 January $200 calls for $25M
- 🎲 Out-of-money bet: $200 strike is 4.2% above current price
- 📈 Leverage play: $16.85 per contract = high delta exposure for recovery rally
- ⏰ Timeline: January 16th (73 days) targets Q4 guidance delivery

What's really happening here:
This trader is executing a classic "extend and reposition" strategy after PLTR's post-earnings selloff. Despite crushing Q3 with 63% revenue growth to $1.18B and raising full-year guidance to $4.4B, the stock dropped 7.9% due to extreme valuation concerns at 254x forward P/E. Rather than panic-selling, institutional money is:

  1. Rolling timeframes out - Moving from November to February on the $160 deep ITM calls to avoid near-term volatility
  2. Adding upside exposure - Betting $25M on recovery to $200 by January, suggesting confidence in Q4 catalyst
  3. Reducing near-term risk - Exiting November expiration before weekly decay accelerates

Translation for regular folks: Smart money isn't bailing on PLTR - they're adjusting their timeline. The post-earnings dip created valuation reset, but the fundamentals (121% U.S. commercial growth, $10B Army contract, £1.5B UK deal) remain intact. This is a "buy the dip with more time" strategy.

Unusual Score: 🔥 EXTREME - Combined $141M in coordinated positioning across multiple expirations and strikes represents institutional-level repositioning.

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

PLTR YTD Performance Chart

Palantir is up +153.7% YTD with a current price of $190.74, despite the recent post-earnings pullback. The chart tells a remarkable growth story - from $75.19 at year start to recent peak of $207, with recent consolidation at $190 level.

Key observations:
- 📈 Parabolic run: From $75 to $207 (175% gain) driven by AIP platform adoption explosion
- 🎢 Massive volatility: 69.9% annualized vol shows this isn't a sleepy enterprise software play
- 📉 Recent pullback: 8% drop from $207 peak after Q3 earnings due to valuation concerns
- 💪 Support holding: Finding buyers at $185-$190 range after selloff
- 📊 Max drawdown: -40.6% earlier in year shows PLTR can move violently in both directions

Gamma-Based Support & Resistance Analysis

PLTR Gamma Support/Resistance Levels

Current Price: $190.74

The gamma exposure map reveals critical price magnets and walls around current levels:

🔵 Support Levels (Put Gamma Below Price):
- $185 - Strongest nearby support with 25.0B total gamma exposure (net -8.4B)
- $180 - Major floor with 30.9B gamma (dealers will buy dips here) - strongest support level
- $175 - Secondary support at 13.7B gamma
- $170 - Deep support with 11.4B gamma
- $165 - Tertiary level at 8.2B gamma
- $160 - Critical floor with 12.1B gamma (where today's massive call buys are positioned!)

🟠 Resistance Levels (Call Gamma Above Price):
- $190 - Immediate resistance with 27.9B gamma (strongest level!) - currently testing
- $195 - Secondary ceiling at 10.6B gamma
- $200 - Major resistance zone with 25.4B gamma (target for the $25M January calls!)
- $210 - Extended resistance at 16.7B gamma

What this means for traders:
The gamma data shows PLTR is trading right at the strongest nearby resistance at $190. Market makers holding these positions will hedge by selling stock as price approaches $190-$195, creating natural resistance. However, the put-heavy positioning at $180-$185 means dealers will buy dips aggressively, creating a strong floor. This setup suggests PLTR could trade range-bound between $180-$200 until the next catalyst emerges.

Net GEX Bias: Slightly Bullish (147.1B call gamma vs 143.7B put gamma = +3.4B net) - Overall positioning is balanced but leans slightly bullish, suggesting market makers are neutral to slightly long delta.

Critical insight: The massive $160 call positions bought today align perfectly with the strong $160 gamma support level. This trader is betting that $160 becomes the floor, with upside to $200 by January.

Implied Move Analysis

PLTR Implied Move Analysis

Options market pricing for upcoming expirations:

  • 📅 Weekly (Nov 7 - 3 days): ±$20.80 (±10.93%) → Range: $174.16 - $215.19
  • 📅 Monthly OPEX (Nov 21 - 17 days): ±$26.07 (±13.70%) → Range: $168.22 - $224.27
  • 📅 Quarterly Triple Witch (Dec 19 - 45 days): ±$33.62 (±17.66%) → Range: $160.80 - $235.63
  • 📅 January OPEX (Jan 16 - 73 days): ±$42.51 (±22.33%) → Range: $156.25 - $242.59
  • 📅 February OPEX (Feb 20 - 108 days): ±$50.93 (±26.75%) → Range: $150.88 - $250.81

Translation for regular folks:
Options traders are pricing in 11% move ($21) by Friday and 14% move ($26) through November expiration. That's MASSIVE volatility for a $491B market cap company! For context, mega-caps like Apple typically see 3-5% implied moves. The market expects continued wild swings as investors digest the valuation debate.

The key dates align perfectly with today's positioning:
- November 21st: Sold calls expire - expecting consolidation in $170-$220 range
- January 16th: $200 call target - market pricing upper range of $242, giving 21% upside
- February 20th: Deep ITM $160 calls - market pricing range of $151-$251, trader betting on staying above $160

Critical observation: The 11% weekly implied move explains why the trader rolled OUT of November - avoiding the violent post-earnings volatility and giving the position 3+ months for catalysts to develop.

🎪 Catalysts

🔥 Recent Catalyst (Just Happened - November 3rd!)

Q3 2025 Earnings Blowout - November 3, 2025 (YESTERDAY!) 📊

Palantir delivered exceptional Q3 results that crushed Wall Street expectations, yet the stock sold off 7.9% due to valuation concerns:

The paradox: Despite crushing every metric, the stock dropped due to extreme valuation concerns at 254x forward P/E (vs Nvidia's 35x). Goldman Sachs called the valuation "extreme" while raising price target to $188. Royal Bank of Canada has $50 price target with "underperform" rating, stating the numbers are "completely disengaged from reality".

Q4 2025 Guidance - RAISED AGAIN! 📊

Palantir provided strong Q4 and full-year guidance that exceeded expectations:

🚀 Immediate Catalysts (Next 60 Days)

AIP Platform Momentum - ONGOING 🤖

Palantir's AIP (Artificial Intelligence Platform) has emerged as the primary growth engine, driving explosive enterprise adoption:

Translation: AIP boot camps are like iPhone launch events - creating massive demand and converting prospects to customers rapidly. The 342% U.S. commercial growth proves enterprise adoption is accelerating beyond expectations.

💰 Major Defense Catalysts (Multi-Year)

$10 Billion U.S. Army Contract - August 2025 🇺🇸

In August 2025, Palantir secured a landmark contract with the U.S. Army worth up to $10 billion over the next decade:

Important note: While the headline is $10B, only $10M has been obligated so far with cash flows expected to materialize in FY 2026 and beyond. This is a long-term revenue stream, not immediate.

£1.5 Billion UK Government Partnership - September 2025 🇬🇧

Palantir's largest foreign government deal announced in September 2025:

Golden Dome Missile Defense System - COMPETING 🛡️

Palantir competing for role in President Trump's "Golden Dome" missile defense initiative:

🤝 Strategic Partnership Catalysts (Recent - October 2025)

Nvidia Partnership - October 2025 🔥

Palantir integrating Nvidia's technology stack into its platforms:

Snowflake Partnership - October 2025 ❄️

Integration of Snowflake's AI Data Cloud with Palantir Foundry:

Lumen Technologies Deal - October 2025 💼

Multi-year partnership worth over $200M:

⚠️ Risk Catalysts (Negative)

Valuation Extreme - ONGOING DEBATE 📊

PLTR trades at historically unprecedented multiples:

Analyst consensus: "Hold" with average price target of $158-$165, suggesting 15-20% downside. Goldman Sachs called valuation "extreme" even while raising price target. D.A. Davidson noted numbers are "completely disengaged from reality".

Bullish analysts:
- Wedbush's Dan Ives: $200 target, calling PLTR on "golden path" to becoming next Oracle in AI
- Piper Sandler: $225 target, growth + margins warrant premium
- Deutsche Bank: $200 target

Bearish analysts:
- Royal Bank of Canada: $50 target with "underperform" rating
- Morningstar: Requires "gradual multiple compression"

U.S. Government Shutdown Impact - MONITORING ⚠️

Ongoing government shutdown entering second month:

  • ⏰ Duration: Multiple weeks and counting
  • 🎯 Exposure: Palantir derives significant revenue from government contracts
  • 💼 Q4 Guidance: Strong outlook suggests minimal near-term impact
  • ⚠️ Risk: Prolonged shutdown could delay contract execution and payments

Competition Intensifying - ONGOING 🥊

PLTR faces increasing competition across government and commercial segments:

📅 Long-Term Growth Outlook (2025-2030)

Analyst projections show continued robust growth:

Morningstar scenarios:
- Base Case: 19% annual revenue growth, 40%+ operating margins
- Bull Case: 24% annual revenue growth, 45% operating margins

🎲 Price Targets & Probabilities

Using gamma levels, implied move data, and upcoming catalysts, here are the scenarios:

📈 Bull Case (35% probability)

Target: $220-$240

How we get there:
- 🚀 Q4 execution: Delivers on $1.33B revenue guidance with continued U.S. commercial acceleration above 100%
- 💰 Army contract funding: $10B Army deal sees significant FY 2026 funding announcement
- 🤝 Partnership wins: Nvidia, Snowflake, Lumen deals convert to material revenue in 2026 guidance
- 🎯 AIP momentum: Boot camp demand continues converting to customers at 100%+ growth rates
- 📊 Multiple expansion: Market re-rates PLTR as "AI infrastructure" play (like Nvidia premium) vs pure software
- 🏛️ Government shutdown resolves: Contract execution accelerates with funding certainty

This aligns with the $200 January calls bought today!

Key risks: Requires sustained multiple expansion despite already extreme valuation. Gamma resistance at $200 significant hurdle.

🎯 Base Case (45% probability)

Target: $175-$200 range

Most likely scenario:
- ✅ Steady execution: Q4 meets guidance, commercial growth moderates to 80-90% (still excellent)
- 📊 Valuation debate continues: Stock trades range-bound as growth bulls fight valuation bears
- 🔄 Contract timing: Army $10B and UK £1.5B deals materialize slowly over quarters
- 📈 2026 guidance: Provides 30-40% growth outlook for next year (strong but decelerating)
- 💪 Strong gamma support: $160-$180 range holds as floor (where $160 calls positioned)
- 🎢 High volatility: Continues trading in wide range as market digests valuation

This is where the trade's sweet spot lives: Stock consolidates in $175-$200 range, the $160 February calls build profit as they move deeper ITM, and the $200 January calls become viable if stock moves toward upper end.

📉 Bear Case (20% probability)

Target: $140-$165

What could go wrong:
- 💔 Q4 disappointment: Growth deceleration more pronounced, commercial momentum stalls below 100%
- 📊 Multiple compression: Valuation concerns win, stock re-rates to 80-100x P/S (still expensive but more reasonable)
- ⚠️ Contract delays: Army $10B funding pushed to late FY 2026, Golden Dome concerns resurface
- 🏛️ Government shutdown extends: Impacts Q1 2026 government revenue growth
- 🥊 Competition intensifies: Databricks, Snowflake, C3.ai win key commercial deals
- 💸 AIP slowdown: Enterprise adoption pace decelerates, boot camp conversion rates normalize
- 📉 Macro selloff: Tech correction drags high-multiple stocks lower

Important note: Even in bear case, the $160 deep ITM calls retain significant intrinsic value. Stock would need to crash below $160 (15% additional downside from here) for those to be underwater. The $200 January calls would expire worthless but represent only $25M of the $141M position (18% of total).

💡 Trading Ideas

🛡️ Conservative: Wait for $175-$180 Support Test

Play: Stay on sidelines until clearer support establishes, then buy shares

Why this works:
- ⏰ Post-earnings volatility still elevated (11% weekly implied move) - too much uncertainty
- 📊 Stock just dropped 8% - could see further profit-taking from other institutional holders
- 🎯 Better entry likely at $175-$180 where strong gamma support exists
- 💪 Recent earnings proved fundamentals remain excellent (63% growth) - just valuation debate
- 📈 Let the dust settle, confirm support holds, then establish position

Action plan:
- 👀 Watch for $175-$180 test over next 1-2 weeks
- ✅ Confirm Q4 guidance trajectory intact through management commentary
- 📊 Monitor AIP momentum indicators - customer adds, TCV growth
- 🎯 If support holds, buy shares for 12-18 month hold targeting $220-$250
- 🛡️ Set mental stop at $165 (major gamma support level)

Risk level: Minimal (cash position, wait for entry) | Skill level: Beginner-friendly

⚖️ Balanced: March Call Spread on Consolidation

Play: After 1-2 weeks consolidation, sell bull call spread March expiration

Structure: Buy $190 calls, Sell $210 calls (March 20, 2026 expiration - 136 days out)

Why this works:
- 🎢 Gives position 4+ months for catalysts to develop (Q4 earnings in February, Army funding news)
- 📊 Defined risk spread ($20 wide = $2,000 max risk per spread)
- 🎯 Targets $190-$210 range which aligns with gamma resistance levels
- ⏰ Avoids near-term weekly volatility (11% implied moves)
- 💰 Captures upside if commercial growth momentum continues without unlimited risk
- 🚀 Benefits from time value decay if position stays ITM

Estimated P&L (indicative pricing):
- 💰 Collect ~$8-10 credit per spread (net debit of $10-12)
- 📈 Max profit: ~$800-1,000 if PLTR at/above $210 at March expiration
- 📉 Max loss: ~$1,000-1,200 if PLTR below $190 (defined and limited)
- 🎯 Breakeven: ~$201-$202
- 📊 Profit zone: $190-$210 (current gamma support/resistance range)

Entry timing: Wait for volatility to compress below 10% weekly implied move (likely 1-2 weeks post-earnings)

Risk level: Moderate (defined risk, directional bias) | Skill level: Intermediate

🚀 Aggressive: Replicate the Institutional Roll (ADVANCED CAPITAL REQUIRED)

Play: Mimic today's sophisticated positioning - roll strategy with upside lottery ticket

Structure:
- Buy $160 deep ITM calls February 2026 (108 days)
- Buy smaller position $200 OTM calls January 2026 (73 days)
- Ratio: 2:1 (for every 2 February $160s, buy 1 January $200)

Why this could work:
- 🏦 Following institutional money: Replicating exactly what sophisticated traders executed today
- 💪 Deep ITM protection: $160 calls have $30+ intrinsic value, limited downside risk
- 🎯 Upside exposure: $200 calls capture explosive move if Q4 catalysts hit
- ⏰ Time diversification: Two expirations reduce timing risk
- 📊 Aligns with fundamentals: 121% commercial growth, $10B Army contract, strategic partnerships support recovery thesis

Why this could blow up (SERIOUS RISKS):
- 💰 MASSIVE CAPITAL: $160 calls trading ~$44 = $4,400 per contract (100 shares = $19,000 effective stock exposure)
- 📉 Valuation risk: At 254x forward P/E, further multiple compression could push below $160
- ⚠️ Analyst targets below entry: Consensus $158-$165 suggests risk to downside
- 🎲 OTM lottery tickets: $200 calls could expire worthless if stock stays range-bound
- 🏛️ Government shutdown: Could extend, impacting Q4/Q1 government revenue
- 🥊 Competition: Databricks, Snowflake wins could slow commercial momentum

Estimated P&L (per 2:1 spread):
- 💰 Cost: ~$10,000 total (2x $160 calls @ $4,400 + 1x $200 call @ $1,700)
- 📈 Max profit: UNLIMITED if stock rallies significantly above $200
- 📉 Max loss: Could lose $3,000-5,000 per spread if stock drops to $150-$160 range
- 🎯 Breakeven: ~$195-$200 range by January/February
- 💰 Effective leverage: Controls 300 shares worth ~$57,000 for $10,000 investment

Position sizing: This is NOT a "max out your account" trade. Allocate maximum 10-15% of options portfolio given concentration risk.

Risk level: HIGH (large capital, directional bet, binary catalysts) | Skill level: Advanced only

⚠️ WARNING: DO NOT attempt this trade unless you:
- Have $10,000+ per spread available (minimum 5 spreads = $50,000 for diversification)
- Can handle losing 30-50% if valuation concerns intensify
- Understand deep ITM options mechanics (intrinsic vs extrinsic value, early assignment risk)
- Can actively monitor position and adjust if fundamentals deteriorate
- Accept that you're betting against consensus analyst price targets

⚠️ Risk Factors

Don't get caught by these potential landmines:

  • 📊 Valuation historically extreme: At 254x forward P/E and 104-120x P/S, PLTR has zero margin for error. Analyst consensus at $158-$165 suggests 15-20% downside risk. Any growth deceleration or execution miss magnified by compressed multiple. Royal Bank of Canada's $50 target (75% downside!) shows bear case exists.

  • 🎢 Extreme volatility continues: 11% weekly implied move, 69.9% annualized volatility means this stock can move $20+ in single day. Post-earnings selloff (7.9% in one day) demonstrates how quickly sentiment shifts. Not for weak stomachs or tight stop-losses.

  • 💰 Contract funding timing uncertain: While headlines tout $10B Army contract and £1.5B UK deal, only $10M actually obligated so far. Cash flows materialize over years, not quarters. Don't bet on immediate revenue impact.

  • 🏛️ Government shutdown overhang: Second month of shutdown creates uncertainty for Q1 2026 government segment (which drives 40%+ of revenue). Prolonged shutdown could delay contracts and payments.

  • 🥊 Competition intensifying rapidly: Databricks, Snowflake, C3.ai plus Microsoft, IBM, Oracle all competing for enterprise AI budgets. Competitors often offer more flexible, cost-effective solutions. Snowflake partnership could help or cannibalize depending on execution.

  • 🤖 AIP momentum sustainability unknown: 121% U.S. commercial growth is incredible but boot camp conversion rates and early customer enthusiasm may not sustain at current pace. Watch for deceleration in Q4/Q1 as tough comps hit.

  • 📊 This trade structure is defensive: The $130M in deep ITM $160 calls plus $50M roll-out of November suggests institutional concern about near-term downside. When smart money extends timeframes and goes defensive, retail should pay attention.

  • ⚠️ Golden Dome execution risk: Army memo highlighting "fundamental security" problems with NGC2 prototype creates doubt about Palantir's ability to execute on massive defense programs. Could lose credibility with DoD.

  • 💸 Insider selling could resume: Following IPO lockup expiration, insiders have historically sold significant stakes. Any major insider selling announcements could trigger retail panic.

🎯 The Bottom Line

Real talk: Someone just deployed $141 MILLION repositioning PLTR options after the stock dropped 8% post-earnings. That's not bearish - it's sophisticated money using the valuation-driven selloff as opportunity to extend timeframes and reduce near-term risk while maintaining massive bullish exposure.

What this trade tells us:
- 🎯 Institutional player believes the pullback is valuation reset, not fundamental deterioration
- 💪 Rolling from November to February shows confidence in 3-6 month recovery, not immediate bounce
- 🚀 Adding $200 January calls suggests expectation of catalyst-driven rally by Q4 earnings
- 📊 Exiting near-term November avoids weekly volatility (11% implied moves) and theta decay
- 💰 Net positioning: Still massively long with $130M deep ITM calls + $25M upside lottery tickets

If you own PLTR:
- ✅ Don't panic: Earnings were exceptional (63% growth, 121% U.S. commercial) - this is valuation debate, not business issue
- 📊 Consider trimming: If you're up 100%+ YTD, take 20-30% off table at $190 - analyst consensus at $158-$165 suggests limited near-term upside
- 🛡️ Set stop at $165: Strong gamma support plus psychological level - breaking below signals deeper correction
- ⏰ Hold remaining 70-80%: Catalysts are real (Army funding, UK deal, partnerships) - just need time to materialize
- 💪 Long-term thesis intact: AIP momentum, defense positioning, strategic partnerships support multi-year growth story

If you're watching from sidelines:
- ⏰ Wait 1-2 weeks: Let post-earnings volatility compress below 10% weekly implied move
- 🎯 Ideal entry: $175-$180 test would offer 8-12% discount from here with strong gamma support
- 📈 Confirm support: Watch for buyers to step in at $175-$180 before committing capital
- 📊 Monitor fundamentals: Q4 guidance of $1.33B must track on schedule via monthly metrics
- 🚀 Size appropriately: This is high-volatility, premium-valuation play - max 5-10% of portfolio

If you're bearish:
- 🎯 Wait for bounce: Fighting 154% YTD momentum is dangerous - let it rally to $200-$210 resistance
- 📊 Watch for cracks: Q4 guidance miss or commercial growth deceleration below 100% would validate bear case
- ⚠️ Put spreads better than shorts: At 254x forward P/E, defined-risk bearish spreads safer than naked shorts
- 💰 Target $165-$175: Major gamma support makes crash below $160 unlikely without fundamental deterioration
- ⏰ Patience required: Valuation compression takes time - this could stay "irrationally expensive" for months

Mark your calendar - Key dates:
- 📅 November 7 (Friday) - Weekly options expiration, post-earnings consolidation
- 📅 November 21 - Monthly OPEX, November $160 calls that were sold today expire
- 📅 December 19 - Quarterly triple witch, significant options expiration
- 📅 January 16, 2026 - $200 call target date from today's trade
- 📅 February 2026 (mid-month) - Q4 2025 earnings, guidance for $1.33B revenue
- 📅 February 20, 2026 - Deep ITM $160 calls expiration date from today's $130M positioning

Final verdict: This is a "use the volatility to reposition" signal from institutional money. The 8% post-earnings drop created opportunity for smart money to extend duration (roll to February), reduce near-term risk (exit November), and add upside exposure ($200 January calls) at attractive entry. The fundamentals remain extraordinary (63% growth, 121% commercial, $10B contracts) - just valuation creates volatility. For patient investors willing to ride 10%+ swings, PLTR offers asymmetric upside if execution continues. For those seeking stability, wait for $175-$180 entry and confirmation of support.

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational purposes only and not financial advice. Past performance doesn't guarantee future results. PLTR's extreme valuation (254x forward P/E, 104x P/S) creates significant downside risk if growth decelerates or market sentiment shifts. The analyst consensus price target of $158-$165 suggests potential 15-20% downside from current levels. The 69.9% annualized volatility means the stock can move 10%+ in single sessions. Always do your own research and consider consulting a licensed financial advisor before trading. Only invest capital you can afford to lose.

About Palantir Technologies Inc.: Palantir develops analytical software designed to help organizations optimize operations through data insights, with a $491.5B market cap operating in the Prepackaged Software industry (SIC: 7372).

Subscribe to AInvest Option Labs

Don’t miss out on the latest issues. Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe